GERMANTOWN, Md.--(BUSINESS WIRE)--Intrexon Corporation, a next generation synthetic biology company, today announced the appointment of Cary P. Moxham, Ph.D., as VP of Alliance Management for its Human Therapeutics alliances. Dr. Moxham’s leadership activities will be focused, first and foremost, on Intrexon’s exclusive channel partnership with ZIOPHARM Oncology, Inc., which was announced on January 6, 2011.
